Global Hyperlipidemia market size is expected to reach $25.54 billion by 2030 at 4.3%, segmented as by familial hyperlipidemia, familial hypercholesterolemia (fh), familial combined hyperlipidemia, familial dysbetalipoproteinemia
Read More
Global Hyperimmune Globulins market size is expected to reach $2.86 billion by 2030 at 6.7%, segmented as by hepatitis b hyperimmune globulin, intramuscular hepatitis b hyperimmune globulin, intravenous hepatitis b hyperimmune globulin
Read More
Global Hyperhidrosis Treatment market size is expected to reach $2.29 billion by 2030 at 6.7%, segmented as by topical treatments, aluminum chloride solutions, antiperspirants
Read More
Global Hypercholesterolemia market size is expected to reach $35.59 billion by 2030 at 13.8%, increasing cardiovascular diseases drives market growth
Read More
Global Hypercalcemia Treatment market size is expected to reach $31.12 billion by 2030 at 11.2%, rising prevalence of parathyroid disorders driving growth in the market
Read More
Global Hyperbaric Oxygen Therapy market size is expected to reach $7.89 billion by 2030 at 9.7%, segmented as by monoplace hyperbaric oxygen therapy, single-chamber monoplace hbot systems, portable monoplace hbot systems
Read More
The hydronephrosis market is projected to reach $5.48 billion by 2030, growing at 10.1% CAGR, driven by aging populations, advanced diagnostics, and minimally invasive urology treatments.
Read More
Global Hydrocortisone market size is expected to reach $2.15 billion by 2030 at 5.7%, segmented as by cream, topical hydrocortisone cream (0.5%, 1%, 2.5%), hydrocortisone ointment
Read More
Global Hyaluronic Acid-based Dermal Fillers market size is expected to reach $9.09 billion by 2030 at 10.7%, the surge in demand for non-invasive dermatology drives hyaluronic acid-based dermal fillers market
Read More
Global Hutchinson-Gilford Progeria Syndrome (HGPS) market size is expected to reach $160 billion by 2030 at 8.5%, the increase in funding for research and development drives market growth
Read More